Joseph Elliot
Corporate Officer/Principal chez Epitopoietic Research Corp.
Profil
Joseph Elliot currently works as a Managing Director & Vice President at Epitopoietic Research Corp.
Postes actifs de Joseph Elliot
| Sociétés | Poste | Début |
|---|---|---|
Epitopoietic Research Corp.
 Epitopoietic Research Corp. BiotechnologyHealth Technology Part of ERC-Belgium SA, Epitopoietic Research Corp. is a clinical stage emerging bio-pharmaceutical company based in Pasadena, CA. The company is developing a safe, highly effective approach for the treatment of cancer using immunotherapy, with particular focus on the treatment of patients with glioblastoma multiforme (GBM), the most deadliest form of brain cancer, using its patented Gliovac/ERC1671 vaccine. The company was founded by Bernard Alliaume, Apostolos Stathopoulos. Apostolos Stathopoulos has been the CEO since incorporation. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Epitopoietic Research Corp.
Epitopoietic Research Corp. BiotechnologyHealth Technology Part of ERC-Belgium SA, Epitopoietic Research Corp. is a clinical stage emerging bio-pharmaceutical company based in Pasadena, CA. The company is developing a safe, highly effective approach for the treatment of cancer using immunotherapy, with particular focus on the treatment of patients with glioblastoma multiforme (GBM), the most deadliest form of brain cancer, using its patented Gliovac/ERC1671 vaccine. The company was founded by Bernard Alliaume, Apostolos Stathopoulos. Apostolos Stathopoulos has been the CEO since incorporation. | Health Technology |
